Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  Published: 17 March 2014

  2587

  PDF: 1346
• 

  Predictors of thickened carotid intima media thickness among well controlled lupus nephritis patients in a Malaysian tertiary centre

  S.S. Shaharir, M.S. Mohamed Said, N.CT. Kong

  341-349

  20-12-2012

  Published: 20 December 2012

  2147

  PDF: 856

• Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

  Ana Martins, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito

  11-11-2024

  Published: 11 November 2024

  879

  PDF: 49
• 

  The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

  M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

  188-194

  31-12-2016

  Published: 31 December 2016

  1696

  PDF: 902
• 

  Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case

  D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav

  302-306

  17-03-2014

  Published: 17 March 2014

  4684

  PDF: 1277

• Cost-of-illness in systemic sclerosis: a retrospective study of an italian cohort of 106 patients

  A. Belotti Masserini, S. Zeni, R. Cossutta, A. Soldi, F. Fantini

  245-255

  Published:

  1213

  PDF: 1128
• 

  Spectrum of musculoskeletal disorders in Nigerians with types 2 diabetes mellitus: prevalence and predictors

  H. Olaosebikan, A. Azenabor, R. Akintayo, O. Adelowo, A. Ogbera, A. Brodie-Mends

  209-217

  28-01-2020

  Published: 28 January 2020

  1953

  PDF: 1135

• Disease disclosure in the workplace in people living with rheumatic diseases: an exploratory study

  S.M.T. Ostuzzi, E.N. Aiello, F. Ingegnoli, C. Pistarini, B. Poletti, V. Silani, E. Fiabane

  01-10-2024

  Published: 1 October 2024

  824

  PDF: 95
• 

  Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis

  S. Chandrashekara, A. Rajendran, A. Bai Jaganath, R. Krishnamurthy

  109-115

  09-02-2016

  Published: 9 February 2016

  2859

  PDF: 1397

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  Published:

  984

  PDF: 683
• 

  Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients

  C.L. Teh, Y.K. Cheong, S.A. Wan, G.R. Ling

  154-159

  24-10-2019

  Published: 24 October 2019

  1810

  PDF: 1046

• LABORATORY FINDINGS IN PSORIATIC ARTHRITIS

  L. Punzi, M. Poswiadek, F. Oliviero, A. Lonigro, V. Modesti, R. Ramonda, S. Todesco

  52-55

  Published:

  2111

  PDF: 1319

• Outcome predictors in rheumatoid arthritis

  C. Montecucco

  21-27

  Published:

  879

  PDF: 907
• 

  Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

  G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

  08-05-2023

  Published: 8 May 2023

  1453

  PDF: 819

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  Published:

  1019

  PDF: 5809
• 

  Systemic lupus erythematosus and infections

  B.K. Singh, S. Singh

  154-169

  19-11-2020

  Published: 19 November 2020

  4222

  PDF: 2338
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  52-59

  10-04-2020

  Published: 10 April 2020

  1871

  PDF: 1056